Showing results (51-60 of 1,875) with videos related to

Sort By:
Pageof 188
Therapeutic Advances in Medical Oncology|February 22, 2021
Update on systemic treatment in early triple negative breast cancerMartín Núñez Abad, Silvia Calabuig-Fariñas, Miriam Lobo de Mena, et al.
Therapeutic Advances in Medical Oncology|February 22, 2021
Methotrexate enhances antigen presentation and maturation of tumour antigen-loaded dendritic cells through NLRP3 inflammasome activation: a strategy for dendritic cell-based cancer vaccineGao-Na Shi, Min Hu, Chengjuan Chen, et al.
Therapeutic Advances in Medical Oncology|February 22, 2021
Baseline lesion number as an efficacy predictive and independent prognostic factor and its joint utility with TMB for PD-1 inhibitor treatment in advanced gastric cancerXiao-Li Wei, Jian-Ying Xu, De-Shen Wang, et al.
Therapeutic Advances in Medical Oncology|February 22, 2021
Effect of cannabis on oxaliplatin-induced peripheral neuropathy among oncology patients: a retrospective analysisBarliz Waissengrin, Dan Mirelman, Sharon Pelles, et al.
Therapeutic Advances in Medical Oncology|August 28, 2020
Long intergenic non-protein coding RNA 00475 silencing acts as a tumor suppressor in glioma under hypoxic condition by impairing microRNA-449b-5p-dependent AGAP2 up-regulationLei Yu, Si Gui, Yawei Liu, et al.
Therapeutic Advances in Medical Oncology|September 10, 2019
The evolving immuno-oncology landscape in advanced lung cancer: first-line treatment of non-small cell lung cancerJia Li Low, Robert J Walsh, Yvonne Ang, et al.
Therapeutic Advances in Medical Oncology|April 29, 2025
Efficacy and safety of radiotherapy to delay second-line systemic therapy in patients with oligoprogressive hepatocellular carcinoma: study protocol of a multicentre, single-arm, phase II trialHaohua Wang, Xiang Zhang, Kunli Zhu, et al.
Therapeutic Advances in Medical Oncology|April 28, 2025
Treatment status, survival and gene expression analysis of large-cell neuroendocrine lung carcinoma: a real-world study in ChinaFei Qi, Minghang Zhang, Yi Han, et al.
Therapeutic Advances in Medical Oncology|April 29, 2025
Corrigendum to "Outcomes of patients with refractory upper GI cancers enrolled in phase I trials: a 10-year analysis from the Sarah Cannon Research Institute UK Drug Development Unit"
Therapeutic Advances in Medical Oncology|March 31, 2025
Prolonged response to osimertinib in three patients with refractory metastatic pancreatic adenocarcinomas with EGFR exon 19 deletion: a case report and literature reviewTimothée Vigié, Alexandre Perrier, Brice Chanez, et al.
Pageof 188